The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1371-1373 , June 2010

Prosthetic heart valves: Difficult to make something simple

  • Didier Lapeyre, MD

      Affiliations

    • Consultant, Chaignes, France
    • Corresponding Author InformationAddress for reprints: Didier Lapeyre, MD, 30 rue du Val du Puits, 27120 Chaignes, France.
    • ,
  • Rolland Siegel, BA

      Affiliations

    • Consultant, Oswego, Ore
    • ,
  • Lawrence Scotten, DiplT

      Affiliations

    • ViVitro Systems Inc, Victoria, British Columbia, Canada
    • ,
  • Bas de Mol, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Academic Medical Center, University of Amsterdam, The Netherlands
    • Sharp Memorial Hospital, San Diego, Calif
    • ,
  • Walter Dembitsky, MD

      Affiliations

    • Sharp Memorial Hospital, San Diego, Calif

References 

  1. Rabelais F. Gargantua and Pantagruel. Urquhart T, Le Motteux, translators. New York: Random House; 1994;
  2. Lund O, Bland M. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;132:20–26
  3. Stassano P, Di Tommaso L, Monaco M, Iorio F, Pepino P, Spampinato N, et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 Years. J Am Coll Cardiol. 2009;54:1862–1868
  4. Tabata M, Umakanthan R, Cohn L, Bolman RM, Shekar PS, Chen FY, et al. Early and late outcomes of 1000 minimally invasive aortic valve operations. Eur J Cardiothorac Surg. 2008;33:537–541
  5. Zilla P, Brink J, Human P, Bezuidenhout D. Prosthetic heart valves: catering for the few. Biomaterials. 2008;29:385–406
  6. Scotten LN, Walker DK. New laboratory technique measures projected dynamic area of prosthetic heart valves. J Heart Valve Dis. 2004;13:120–133
  7. Wolf LG, Choudhary BP, Abu-Omar Y, Taggart DP. Solid and gaseous cerebral microembolization after biologic and mechanical aortic valve replacement: investigation with multirange and multifrequency transcranial Doppler ultrasound. J Thorac Cardiovasc Surg. 2008;135:512–520
  8. Bluestein D, Chandran KB, Manning KB. Towards non-thrombogenic performance of blood recirculating devices. Ann Biomed Eng. 2010;38:1236–1256
  9. Govindarajan V, Udaykumar HS, Chandran KB. Two-dimensional simulation of flow and platelet dynamics in the hinge region of a mechanical heart valve. Ann Biomech Eng. 2009;131:031002
  10. Dasi LP, Simon HA, Sucosky P, Yoganathan AP. New frontiers in biomedical engineering. Fluid mechanics of artificial heart valves. Clin Exp Pharmacol Physiol. 2009;36:225–237
  11. Mack M. Fool me once, shame on you; fool me twice, shame on me! A perspective on the emerging world of percutaneous heart valve therapy. J Thorac Cardiovasc Surg. 2008;136:816–819
  12. Leriche R. Philosophie de la chirurgie. Paris, France: Flammarion; 1951;267
  13. Lillehei CW. New ideas and their acceptance. As it has related to preservation of chordae tendinea and certain other discoveries. J Heart Valve Dis. 1995;4(Suppl 2):S106–S114
  14. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the Society for Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523–e661
  15. Piper C, Hering D, Kleikamp G, Korfer R, Horstkotte D. Valve replacement in octogenarians: arguments for an earlier surgical intervention. J Heart Valve Dis. 2009;18:239–244
  16. Chen E, Sapirstein W, Ahn C, Swain J, Zuckerman B. Perspective on clinical trial design for cardiovascular devices. Ann Thorac Surg. 2006;82:773–775
  17. Siddiqui RF, Abraham JR, Butany J. Bioprosthetic heart valves: modes of failure. Histopathology. 2009;55:135–144
  18. Zegdi R, Achouh P, Fabiani JN. Percutaneous aortic valve replacement with the CoreValve bioprosthesis. J Thorac Cardiovasc Surg. 2008;135:1407–1408
  19. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2008;34:1–8
  20. Chiam P, Ruiz CE. Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective. JACC Cardiovasc Interv. 2008;1:341–350
  21. Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David TE. Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009;87:521–525
  22. Walther T, Dewey T, Borger MA, Kempfert J, Linke A, Becht R, et al. Transapical aortic valve implantation: step by step. Ann Thorac Surg. 2009;87:276–283
  23. Van Brabandt H, Neyt M. Safety of percutaneous aortic valve insertion. A systematic review. BMC Cardiovasc Disord. 2009;9:45
  24. Takkenberg JJ, Rajamannan NM, Rosenhek R, Kumar AS, Carapetis JR, Yacoub MH, et al. The need for a global perspective on heart valve disease epidemiology. The SHVD working group on epidemiology of heart valve disease founding statement. J Heart Valve Dis. 2008;17:135–139

PII: S0022-5223(10)00170-4

doi: 10.1016/j.jtcvs.2010.02.026

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 6 , Pages 1371-1373 , June 2010

Article Tools